93 results
Page 4 of 5
8-K
3sok6yg3k5g5wehulx
14 Nov 19
Regulation FD Disclosure
10:23am
DEFA14A
0k0g0fvjaq93l
12 Nov 19
Additional proxy soliciting materials
6:26am
8-K
ux3l99
12 Nov 19
Regulation FD Disclosure
6:24am
PRER14A
il2pw39teia36no
6 Nov 19
Preliminary revised proxy
12:00am
CORRESP
dhrmkyszgksi
5 Nov 19
Correspondence with SEC
12:00am
UPLOAD
que3346u dttdm3fe
31 Oct 19
Letter from SEC
12:00am
DEFA14A
ph85zisvo ff42syl
29 Oct 19
Additional proxy soliciting materials
1:50pm
8-K
ms9xop9at246la
29 Oct 19
This report is prepared solely for the use of John Strumbos
1:48pm
DEFA14A
npja jercsbei4
15 Oct 19
Additional proxy soliciting materials
7:01am
8-K
dqhfbz
15 Oct 19
Regulation FD Disclosure
7:00am
DEFA14A
sw2pd6yu480 yjlg
8 Oct 19
Additional proxy soliciting materials
4:28pm
DEFA14A
EX-99.1
f2mcswmx3n
8 Oct 19
Additional proxy soliciting materials
4:28pm
8-K
EX-99.1
fae 0pt59b6n0qm5a5x
8 Oct 19
Regulation FD Disclosure
4:26pm
8-K
vheuepuhtjfj
8 Oct 19
Regulation FD Disclosure
4:26pm
DEFA14A
1z2ccm b97
4 Oct 19
Additional proxy soliciting materials
4:55pm
8-K
6a4nf5 2zo920aqg
4 Oct 19
Chardan Advises Health Sciences Acquisitions Corporation on Merger with Immunovant
4:53pm
PREM14A
sw83t8bwvkezvab
2 Oct 19
Preliminary proxy related to merger
9:58am
8-K
lji mufcw1li
2 Oct 19
Creating New Publicly Listed FcRn-Focused Company
7:30am
8-K
EX-2.1
rnzxq3zikk1 9ef
2 Oct 19
Creating New Publicly Listed FcRn-Focused Company
7:30am
8-K
EX-99.1
cg7qno6bhgerqmeakyio
2 Oct 19
Creating New Publicly Listed FcRn-Focused Company
7:30am